The ATP-sensitive potassium channel (K-ATP) has been shown to serve an
endogenous cardioprotective role in a number of experimental models o
f myocardial stunning and infarction. More importantly, a majority of
evidence has also been obtained which suggests that the K-ATP channel
may be intimately involved in both triggering and maintaining the card
ioprotection afforded by the phenomenon of ischemic preconditioning pa
rticularly in large animal models such as dogs and pigs. Although the
evidence for an involvement of K-ATP in ischemic pre-conditioning is e
quivocal in smaller animal species such as rabbits and rats, activatio
n of this channel by K-ATP channel openers produces cardioprotection i
n all species studied. Whether this channel is an important mediator o
f ischemic preconditioning in all animal species including man and the
mechanism by which this cardioprotective effect is obtained await fur
ther experimental studies. Nevertheless, the use of selective potassiu
m channel openers to mimic preconditioning in selected clinical settin
gs maybe a desirable future therapeutic goal.